Serina Therapeutics (SER) EPS (Basic) (2018 - 2026)
Serina Therapeutics (SER) posted EPS (Basic) of -$0.63 for Q4 2025, down 0.88% sequentially from -$0.62 in Q3 2025, and up 22.04% YoY from -$0.51 in Q4 2024.
Serina Therapeutics (SER) EPS (Basic) (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported EPS (Basic) for 8 years, with the latest figure at -$0.63 in Q4 2025.
- Quarterly EPS (Basic) rose 22.04% year-over-year to -$0.63 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.46 (up 3.93% YoY) and the FY2025 annual result came in at -$1.91, down 25.99% from the prior year.
- EPS (Basic) retreated to -$0.63 in Q4 2025 per SER's latest filing, from -$0.62 in the prior quarter.
- Over five years, EPS (Basic) peaked at $403.15 in Q4 2023 and troughed at -$2426.3 in Q2 2022.
- A 5-year average of -$262.45 and a median of -$0.8 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) plunged 37383462.37% in 2022, then soared 24505.71% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.01 in 2021, then plunged by 25352.45% to -$1.65 in 2022, then surged by 24505.71% to $403.15 in 2023, then slumped by 100.2% to -$0.8 in 2024, then gained by 22.04% to -$0.63 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.63, -$0.62, and -$0.6 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.18 |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | -0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.55 |
| Dec 31, 2025 | -0.63 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -0.60 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.80 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -526.43 |
| Mar 31, 2024 | -1.08 |
| Dec 31, 2023 | 403.15 |
| Sep 30, 2023 | -1,448.56 |
| Jun 30, 2023 | -975.90 |
| Mar 31, 2023 | -0.97 |
| Dec 31, 2022 | -1.65 |
| Sep 30, 2022 | -2.26 |
| Jun 30, 2022 | -2,426.32 |
| Mar 31, 2022 | -2.51 |
| Sep 30, 2021 | -0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | -0.10 |